A case of delayed antihistamine cutaneous drug eruption and piperidine derivative cross‐ reaction

2021 ◽  
Author(s):  
Mathieu Lagassy ◽  
Marine Aroux‐Pavard ◽  
Pascal Joly ◽  
Florence Tetart ◽  
Olivia Bauvin
Keyword(s):  
Drug Eruption ◽  
Cross Reaction ◽  
Piperidine Derivative

Fixed Drug Eruption Cross Reaction Of Meprobamate and Carisoprodol

1965 ◽  
Vol 91 (6) ◽  
pp. 627 ◽  
Author(s):  
HERSCHEL C. GORE
Keyword(s):  
Drug Eruption ◽  
Cross Reaction ◽  
Fixed Drug Eruption ◽  
Fixed Drug

scholarly journals Fixed drug eruption due to cross reaction between two azoles used for different indications

2008 ◽  
Vol 74 (1) ◽  
pp. 81
Author(s):  
M Ramam ◽  
Arika Bansal ◽  
Rashmi Kumari
Keyword(s):  
Drug Eruption ◽  
Cross Reaction ◽  
Fixed Drug Eruption ◽  
Fixed Drug

Fixed Drug Eruption to Carisoprodol and Cross Reaction with Meprobamate

JAMA ◽  
1962 ◽  
Vol 180 (8) ◽  
pp. 691 ◽  
Author(s):  
Wesley M. Honeycutt
Keyword(s):  
Drug Eruption ◽  
Cross Reaction ◽  
Fixed Drug Eruption ◽  
Fixed Drug

scholarly journals A case of levocetirizine-induced fixed drug eruption and cross-reaction with piperazine derivatives

2013 ◽  
Vol 3 (4) ◽  
pp. 281 ◽  
Author(s):  
Mi-Yeong Kim ◽  
Eun-Jung Jo ◽  
Yoon-Seok Chang ◽  
Sang-Heon Cho ◽  
Kyung-Up Min ◽  
...  
Keyword(s):  
Drug Eruption ◽  
Cross Reaction ◽  
Fixed Drug Eruption ◽  
Piperazine Derivatives ◽  
Fixed Drug

Identification of dimenhydrinate as the causative agent in fixed drug eruption using patch‐testing in previously affected skin

1998 ◽  
Vol 138 (5) ◽  
pp. 920-921 ◽  
Author(s):  
Smola ◽  
Kruppa ◽  
Hunzelmann ◽  
Krieg ◽  
Scharffetter‐Kochanek
Keyword(s):  
Causative Agent ◽  
Patch Testing ◽  
Drug Eruption ◽  
Fixed Drug Eruption ◽  
Fixed Drug

Fixed-drug eruption to tetracycline

1970 ◽  
Vol 101 (5) ◽  
pp. 621b-621 ◽  
Author(s):  
M. B. Brodin
Keyword(s):  
Drug Eruption ◽  
Fixed Drug Eruption ◽  
Fixed Drug

Pharmacodynamics of [D-Ser (t-Bu), Des-Gly]GnRH ethylamide (Buserelin®) in 6 normal volunteers.

1987 ◽  
Vol 115 (2) ◽  
pp. 235-242 ◽  
Author(s):  
Y. Reznik ◽  
B. P. Winiger ◽  
M. L. Aubert ◽  
P. C. Sizonenko
Keyword(s):  
Urinary Excretion ◽  
Precocious Puberty ◽  
Plasma Levels ◽  
Intranasal Administration ◽  
Cross Reaction ◽  
Disappearance Rate ◽  
Gnrh Analog ◽  
Male Adolescents ◽  
Normal Volunteers ◽  
The Mean

Abstract. The disappearance rate of [D-Ser(t-bu)6,des-Gly10]GnRH ethylamide (Buserelin®, HOE 766) was studied in plasma and urine after intranasal (300 μg) or sc (10 μg/kg) administration. A radioimmunoassay for HOE 766 was developed using 125I[D-Trp6,Des-Gly10]GnRH ethylamide as tracer and an antiserum raised against HOE 766. Cross-reaction with native GnRH was only 1.7%. Sensitivity was 1 pg/tube. In 6 male adolescents, the mean plasma HOE 766 concentration (± sem) was 0.46 ± 0.08, 0.50 ± 0.10, 0.28 ± 0.04, 0.24 ± 0.04, 0.13 ± 0.03, and 0.08 ± 0.02 μg/l 30, 60, 90, 120 and 180 min after the intranasal administration, respectively. Concomitant urinary excretion of HOE 766-like material was 9.43 ± 1.96 μg/4 h. There was a good correlation between integrated plasma levels and urinary excretion (r = 0.92). In the same 6 volunteers, the plasma HOE 766 levels were 21.2 ± 3.0, 25.9 ± 0.8, 21.2 ± 0.9, 17.1 ± 0.7, 12.8 ± 1.1, 8.9 ± 0.4, and 5.9 ± 0.8 μg/l 20, 40, 60, 90, 120, 180 and 240 min after sc injection, respectively. The mean urinary excretion was 543 ± 61 μg/4 h. In two girls with precocious puberty treated during 12 to 15 months with intranasal administration of HOE 766, urinary excretion of HOE 766-like material was shown to correlate well with the degree of inhibition of plasma 17β-E2and of plasma LH and FSH responses to a GnRH challenge. Thus, monitoring of HOE 766 in urine appears to be helpful for evaluating of intranasal therapy with a GnRH analog in precocious puberty.

Drug Eruption Associated with Agranulocytosis and Hepatic Injury

1976 ◽  
Vol 38 (2) ◽  
pp. 249-253
Author(s):  
Hideaki YAMAURA ◽  
Isamu TAKAHASHI ◽  
Kazuo SASAOKA ◽  
Akira INOUE
Keyword(s):  
Drug Eruption ◽  
Hepatic Injury

Observations on the Ultrastructure of the So-called Colloid Bodies in Lichen Planus and Lichenoid Drug Eruption

1975 ◽  
Vol 37 (4) ◽  
pp. 541-552 ◽  
Author(s):  
Tamiko ISHIKURA
Keyword(s):  
Lichen Planus ◽  
Drug Eruption
Sign in / Sign up

Export Citation Format

Share Document